Cassava Sciences, Inc. SAVA
Set alert
1.32 USD 0.00 0.00%
As of May 22, 12:35 PM ET
1.27 Day range 1.35
1.87 52-week range 3.56
- YTD
- -33.33%
- 1 year
- -25.42%
- Open
- 1.30
- Prev close
- 1.32
- Mkt cap
- 63.77M
- Vol
- 134.26K
- Avg vol
- 722.67K
- EPS
- -2.19
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.27
- High
- 1.35
- Forward P/E
- -1.36
- Beta
- -0.58
- Short ratio
- 1.95
- Inst. own
- 29.93%
- Dividend
- 0.00
- Ex-div date
- Dec 12, 2012
- 50-d avg
- 17.99
- 200-d avg
- 21.09
- 1y target
- 0.00
5Y chart
Events in this range
- Aug 3, 2023Earnings: -0.63; estimate -0.58; surprise -8.62%
- Feb 28, 2024Earnings: -0.5; estimate -0.4; surprise -25%
- May 10, 2024Earnings: -1.41; estimate -0.51; surprise -176.47%
- Jul 19, 2024Rating: HC Wainwright & Co. · — → Neutral
- Aug 8, 2024Rating: Rodman & Renshaw · Buy → Buy
- Aug 8, 2024Earnings: -1.28; estimate -0.44; surprise -190.91%
- Aug 13, 2024Rating: HC Wainwright & Co. · — → Neutral
- Oct 8, 2024Rating: HC Wainwright & Co. · Neutral → Buy
- Nov 7, 2024Earnings: -0.58; estimate -1.37; surprise 57.66%
- Nov 8, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 26, 2024Downgrade: HC Wainwright & Co. · Buy → Neutral
Signals (84)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Mar 11, 2026 | 7 months ago |
| SMA: Bullish | Feb 24, 2026 | 8 months ago |
| SMA: Bearish | Dec 23, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 2, 2025 | 11 months ago |
| SMA: Bearish | Nov 4, 2025 | 12 months ago |
| RSI: Overbought | Oct 6, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Jul 14, 2025 | 1 year ago |
| SMA: Bearish | Jun 30, 2025 | 1 year ago |
| MACD: Buy Signal | May 23, 2025 | 1 year ago |
| SMA: Bullish | May 16, 2025 | 1 year ago |
| SMA: Bearish | Mar 27, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 27, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 20, 2025 | 1 year ago |
| SMA: Bullish | Feb 20, 2025 | 1 year ago |
| SMA: Bearish | Dec 3, 2024 | 1 year ago |
| SMA: Bearish | Nov 26, 2024 | 1 year ago |
| SMA: Bullish | Nov 19, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 5, 2024 | 1 year ago |
| SMA: Bearish | Oct 28, 2024 | 2 years ago |
| SMA: Bullish | Oct 21, 2024 | 2 years ago |
| SMA: Bearish | Oct 7, 2024 | 2 years ago |
| SMA: Bullish | Aug 5, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 5, 2024 | 2 years ago |
| SMA: Bullish | Jul 29, 2024 | 2 years ago |
| SMA: Bearish | Jun 10, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 10, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 3, 2024 | 2 years ago |
| SMA: Bearish | May 24, 2024 | 2 years ago |
| SMA: Bullish | May 17, 2024 | 2 years ago |
| SMA: Bullish | May 17, 2024 | 2 years ago |
| SMA: Bearish | May 10, 2024 | 2 years ago |
| SMA: Bullish | Apr 26, 2024 | 2 years ago |
| SMA: Bullish | Apr 26, 2024 | 2 years ago |
| SMA: Bearish | Apr 19, 2024 | 2 years ago |
| SMA: Bearish | Apr 19, 2024 | 2 years ago |
| SMA: Bullish | Apr 12, 2024 | 2 years ago |
| SMA: Bullish | Apr 12, 2024 | 2 years ago |
| SMA: Bearish | Mar 7, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 7, 2024 | 2 years ago |
| SMA: Bearish | Feb 15, 2024 | 2 years ago |
| SMA: Bullish | Feb 8, 2024 | 2 years ago |
| SMA: Bearish | Feb 1, 2024 | 2 years ago |
| SMA: Bullish | Dec 14, 2023 | 2 years ago |
| SMA: Bearish | Nov 30, 2023 | 2 years ago |
| SMA: Bullish | Nov 8, 2023 | 2 years ago |
| SMA: Bullish | Oct 31, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 31, 2023 | 3 years ago |
| SMA: Bearish | Oct 17, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 17, 2023 | 3 years ago |
| SMA: Bullish | Oct 10, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 10, 2023 | 3 years ago |
| SMA: Bearish | Sep 12, 2023 | 3 years ago |
| SMA: Bullish | Aug 29, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 25, 2023 | 3 years ago |
| SMA: Bearish | Jul 11, 2023 | 3 years ago |
| SMA: Bullish | Jul 3, 2023 | 3 years ago |
| SMA: Bearish | Jun 27, 2023 | 3 years ago |
| SMA: Bullish | Jun 13, 2023 | 3 years ago |
| SMA: Bearish | May 30, 2023 | 3 years ago |
| MACD: Buy Signal | May 16, 2023 | 3 years ago |
| SMA: Bullish | May 9, 2023 | 3 years ago |
| SMA: Bearish | Jan 24, 2023 | 3 years ago |
| SMA: Bearish | Jan 24, 2023 | 3 years ago |
| SMA: Bullish | Jan 17, 2023 | 3 years ago |
| SMA: Bullish | Jan 10, 2023 | 3 years ago |
| MACD: Sell Signal | Jan 3, 2023 | 3 years ago |
| SMA: Bearish | Dec 27, 2022 | 3 years ago |
| SMA: Bearish | Dec 27, 2022 | 3 years ago |
| SMA: Bullish | Dec 13, 2022 | 3 years ago |
| SMA: Bearish | Nov 22, 2022 | 3 years ago |
| SMA: Bullish | Nov 15, 2022 | 3 years ago |
| SMA: Bearish | Nov 8, 2022 | 3 years ago |
| SMA: Bullish | Sep 12, 2022 | 4 years ago |
| SMA: Bullish | Aug 22, 2022 | 4 years ago |
| SMA: Bearish | Jul 11, 2022 | 4 years ago |
| SMA: Bullish | Jun 17, 2022 | 4 years ago |
| SMA: Bearish | Jun 13, 2022 | 4 years ago |
| SMA: Bullish | May 27, 2022 | 4 years ago |
| RSI: Oversold | Apr 11, 2022 | 4 years ago |
| RSI: Oversold | Mar 7, 2022 | 4 years ago |
| SMA: Bearish | Feb 28, 2022 | 4 years ago |
| SMA: Bullish | Feb 7, 2022 | 4 years ago |
Key statistics
- Market cap
- 115.95M
- Enterprise value
- -35.92M
- Trailing P/E
- 0.00
- Forward P/E
- -1.36
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.69
- EPS (TTM)
- -1.38
- Beta
- -0.58
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -82.64M
- Total cash
- 148.98M
- Total debt
- 0
- Return on equity
- -10.98%
- Shares outstanding
- 48.11M
- Short % of float
- 38.06%
- 50-day average
- 17.99
- 200-day average
- 21.09
Analyst view
Consensus: none
Price target (mean) 0.00
Ratings (0m) 2 0 buy · 2 hold · 0 sell
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.68.
Financials — quick view
SAVA Revenue — quarterly 0
SAVA Net income — quarterly -10.81M
SAVA EPS — quarterly -0.22
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | -1.37 | -0.58 | +0.79 | +57.66% |
| Aug 8, 2024 | Jun 1, 2024 | -0.44 | -1.28 | -0.84 | -190.91% |
| May 10, 2024 | Mar 1, 2024 | -0.51 | -1.41 | -0.90 | -176.47% |
| Feb 28, 2024 | Dec 1, 2023 | -0.40 | -0.50 | -0.10 | -25.00% |
| Nov 7, 2023 | Sep 1, 2023 | -0.90 | -0.61 | +0.29 | +32.22% |
| Aug 3, 2023 | Jun 1, 2023 | -0.58 | -0.63 | -0.05 | -8.62% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 26, 2024 | HC Wainwright & Co. | down | Buy | Neutral |
| Nov 8, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Oct 8, 2024 | HC Wainwright & Co. | up | Neutral | Buy |
| Aug 13, 2024 | HC Wainwright & Co. | reit | — | Neutral |
| Aug 8, 2024 | Rodman & Renshaw | reit | Buy | Buy |
| Jul 19, 2024 | HC Wainwright & Co. | reit | — | Neutral |
About Cassava Sciences, Inc.
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- cassavasciences.com
News
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- HALPER SADEH LLC ENCOURAGES CASSAVA SCIENCES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
- Cassava Announces Agreement to Settle Securities Class Action Litigation
- 12 Health Care Stocks Moving In Friday's Intraday Session
- FDA Puts Cassava's Simufilam Epilepsy Trial On Full Clinical Hold
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- 12 Health Care Stocks Moving In Monday's After-Market Session
- Comparing Cassava Sciences (NASDAQ:SAVA) and Carisma Therapeutics (NASDAQ:CARM)
- Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Your note
Sign in to keep a note on SAVA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARBIER REMI | Chief Executive Officer | Conversion of Exercise of derivative security | May 23, 2023 | 0 |
| BARRY RICHARD J | Director | Conversion of Exercise of derivative security | Apr 22, 2024 | 0 |
| GUSSIN ROBERT Z | Director | Conversion of Exercise of derivative security | Apr 30, 2023 | 10,617 |
| KUPIEC JAMES WILLIAM | Officer | Sale | Nov 28, 2024 | 0 |
| O DONNELL MICHAEL J | Director | Conversion of Exercise of derivative security | Mar 6, 2023 | 6,873 |
| ROBERTSON SANFORD R | Director | Stock Gift | May 15, 2024 | 1,135,850 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 6.78% | 3,263,474 | 7.86M | Sep 29, 2024 |
| Vanguard Group Inc | 5.24% | 2,522,798 | 6.08M | Sep 29, 2024 |
| State Street Corporation | 2.42% | 1,162,749 | 2.80M | Sep 29, 2024 |
| Geode Capital Management, LLC | 2.10% | 1,008,593 | 2.43M | Sep 29, 2024 |
| Gallacher Capital Management LLC | 1.21% | 580,042 | 1.40M | Sep 29, 2024 |
| Morgan Stanley | 1.08% | 519,544 | 1.25M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.65% | 1,275,948 | 3.08M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.17% | 1,045,518 | 2.52M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.41% | 678,626 | 1.64M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.86% | 415,510 | 1.00M | Aug 30, 2024 |
| iShares Russell 2000 Growth ETF | 0.75% | 362,957 | 874.73K | Oct 30, 2024 |
| Fidelity Extended Market Index Fund | 0.52% | 251,560 | 606.26K | Oct 30, 2024 |